Ignite Creation Date:
2025-12-24 @ 11:28 PM
Ignite Modification Date:
2026-01-02 @ 1:25 AM
Study NCT ID:
NCT04646356
Status:
COMPLETED
Last Update Posted:
2025-04-01
First Post:
2020-10-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Tacrolimus Trial for Hereditary Hemorrhagic Telangiectasia (HHT)
Sponsor:
Unity Health Toronto
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
170518448
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | FED | View |